News

The Greater Bay Area International Clinical Trial Institute (GBAICTI) is pleased to announce the establishment of the Real-World Study and Application Centre (RWSAC), and the launch of the GBA Clinical Trial Collaboration Platform.

The RWSAC will leverage Hong Kong's unique advantages in medical data to enhance access to and the application of health and medical databases, and integrate real-world data generated under the special measure of using Hong Kong-registered drugs and medical devices used in Hong Kong public hospitals in the GBA, with a view to supporting registration applications for innovative drugs and medical devices in Hong Kong, the Mainland and overseas, thereby accelerating product research and development, approval and market launch. See more details at: https://www.info.gov.hk/gia/general/202512/22/P2025122200201.htm

The simultaneously launched Collaboration Platform is a unified service portal jointly established by the "one institute, one center", aiming to integrate GBA clinical trial resources and provide a one-stop service entry point for global biomedical enterprises, R&D institutions and researchers. For this collaboration between the Greater Bay Area International Clinical Trial Institute and the Greater Bay Area International Clinical Trials Center, refer to https://gba-clinicaltrials.com/en/news-and-events/7gtlEJfNhk4Rkt7oue7MwA